AstraZeneca signs strategic partnership with Beijing; invests $2.5bn
The pharmaceutical firm expects its workforce in Beijing to grow to 1,700 employees and is launching a JV with BioKangtai to help make vaccines; there is also investment into AI.
March 25, 2025







.jpg&h=171&w=304&q=75&v=bbb403448b&c=1)
.jpg&h=171&w=304&q=75&v=bbb403448b&c=1)
